Skip to Main Content

Author Details

Wei Li
The Ohio State University
2005
43
27
PMIDPaper TitleJournal TitlePublished Year
38062777<i>PDPR</i> Gene Variants Predisposing to Papillary Thyroid Cancer.Thyroid2024
37051697The <i>RCAN1.4</i> Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer.Thyroid2023
35941416Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease.Mol Biol Rep2022
33943044A novel essential splice site variant in SPTB in a large hereditary spherocytosis family.Mol Genet Genomic Med2021
34238982Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma.Sci Rep2021
31928178A Truncating Germline Mutation of <i>TINF2</i> in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.Thyroid2020
30654714Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.Thyroid2019
30957677Identification of Rare Variants Predisposing to Thyroid Cancer.Thyroid2019
29121253The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.J Clin Endocrinol Metab2018
30043374Genome-Wide TSS Identification in Maize.Methods Mol Biol2018
29768105Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.Thyroid2018
29300379The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.Genet Med2018
28031538Variants in microRNA genes in familial papillary thyroid carcinoma.Oncotarget2017
28049826MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.Proc Natl Acad Sci U S A2017
27871810A Maize Gene Regulatory Network for Phenolic Metabolism.Mol Plant2017
26899186Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.Anticancer Agents Med Chem2016
27480690Establishing the Architecture of Plant Gene Regulatory Networks.Methods Enzymol2016
27296473Primary Cell Culture Systems for Human Thyroid Studies.Thyroid2016
27342578Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.Thyroid2016
27459529Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.J Clin Endocrinol Metab2016
25303483Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.J Clin Endocrinol Metab2015
26628745Core Promoter Plasticity Between Maize Tissues and Genotypes Contrasts with Predominance of Sharp Transcription Initiation Sites.Plant Cell2015
26301496Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes.Nat Genet2015
26274343PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.J Clin Endocrinol Metab2015
25918370Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.Proc Natl Acad Sci U S A2015
25940622The SOX9 upstream region prone to chromosomal aberrations causing campomelic dysplasia contains multiple cartilage enhancers.Nucleic Acids Res2015
25727450Important biological information uncovered in previously unaligned reads from chromatin immunoprecipitation experiments (ChIP-Seq).Sci Rep2015
25535248Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.EMBO J2015
24586183Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.PLoS Genet2014
25053252The Maize TFome--development of a transcription factor open reading frame collection for functional genomics.Plant J2014
23539728SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.J Clin Endocrinol Metab2013
23690926Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.PLoS One2013
23659773Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.Thyroid2013
22136206MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.Thyroid2012
22586128The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.Proc Natl Acad Sci U S A2012
22267200Discovery of common variants associated with low TSH levels and thyroid cancer risk.Nat Genet2012
21474760Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I.Science2011
21900400Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer.Cancer Res2011
21318127Histone modifications and chromatin organization in prostate cancer.Epigenomics2010
19198613Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.Nat Genet2009
19147577A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.Cancer Res2009
18787043Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.Mol Endocrinol2008
16365291The role of microRNA genes in papillary thyroid carcinoma.Proc Natl Acad Sci U S A2005
  • 1 - 43 of 43

Recommended Authors

The University of Texas at Austin
Career Start Year 2010
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 0
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 4
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 1
Arizona State University
Career Start Year 2005
Number of shared co-authors 0
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 1
University of Salerno and Genome Research Center for Health
Career Start Year 2004
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Hospital Sirio Libanes
Career Start Year 2003
Number of shared co-authors 0
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 2
Instituto Metropole Digital, Universidade Federal do Rio Grande do Norte
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 1
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 0
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 1
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 1
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 4
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Case Western Reserve University School of Medicine
Career Start Year 1995
Number of shared co-authors 2
University of British Columbia
Career Start Year 1995
Number of shared co-authors 1
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 3
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
University of British Columbia
Career Start Year 1993
Number of shared co-authors 1
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year 1991
Number of shared co-authors 0
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 0
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 0

Collaborators

The Ohio State University Comprehensive Cancer Center
Co-authored papers 27
The Ohio State University Comprehensive Cancer Center
Co-authored papers 27
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Co-authored papers 24
Guardant Health Inc.
Co-authored papers 15
The Ohio State University College of Medicine and Comprehensive Cancer Center
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Biological and Chemical Research Centre, University of Warsaw
Co-authored papers 5
Veracyte Inc.
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
The Ohio State University School of Medicine
Co-authored papers 3
AGH University of Science and Technology
Co-authored papers 3
Medical University of Warsaw
Co-authored papers 3
The Ohio State University
Co-authored papers 3
Maria Sklodowska-Curie Institute - Oncology Centre
Co-authored papers 3
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Co-authored papers 3
Co-authored papers 2
The Wistar Institute
Co-authored papers 2
deCODE genetics/Amgen Inc.
Co-authored papers 2
Co-authored papers 2
University of Iceland
Co-authored papers 2
Co-authored papers 2
Folkhalsan Research Center, University of Helsinki
Co-authored papers 2
Co-authored papers 2
Comprehensive Cancer Center, The Ohio State University
Co-authored papers 2
Co-authored papers 2
Medical University of Warsaw
Co-authored papers 2
University of Texas Health San Antonio (UTHSA)
Co-authored papers 2
Emory University
Co-authored papers 2
Co-authored papers 2